Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-,phenylcarbamate (ester), (3aS,8aR)-


Chemical Name: Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-,phenylcarbamate (ester), (3aS,8aR)-
CAS Number: 101246-66-6
Product Number: AG00041U(AGN-PC-0OQHHZ)
Synonyms:
MDL No: MFCD00672748
Molecular Formula: C20H23N3O2
Molecular Weight: 337.4155

Identification/Properties


Computed Properties
Molecular Weight:
337.423g/mol
XLogP3:
2.3
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
3
Exact Mass:
337.179g/mol
Monoisotopic Mass:
337.179g/mol
Topological Polar Surface Area:
44.8A^2
Heavy Atom Count:
25
Formal Charge:
0
Complexity:
507
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
2
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Phenserine, a potent acetylcholinesterase inhibitor, plays a crucial role in chemical synthesis as a key component in the development of pharmaceutical compounds. Utilized in the synthesis of novel drug candidates, Phenserine serves as a catalyst for reactions that require enzymatic inhibition, particularly in the field of Alzheimer's research. Its unique molecular structure enables precise control over cholinergic pathways, making it a valuable tool for designing therapeutic agents that target neurodegenerative diseases. In combination with other reagents, Phenserine facilitates the creation of cutting-edge medications that hold promise for advancing the treatment of cognitive disorders.